Related Experiment Videos
Alopecia areata and interleukin-2 receptor
R Valsecchi1, G Imberti, D Martino
1Department of Dermatology, Ospedali Riuniti, Bergamo, Italy.
Dermatology (Basel, Switzerland)
|January 1, 1992
Summary
Soluble Interleukin-2 Receptor (sIL-2R) levels indicate T cell activation. Active alopecia areata shows significantly higher sIL-2R than stable disease or healthy controls, suggesting immune involvement.
Area of Science:
- Immunology
- Dermatology
- Biochemistry
Background:
- Interleukin-2 (IL-2) is a key cytokine in T cell function.
- The Interleukin-2 Receptor (IL-2R) is expressed on T cells.
- Soluble IL-2R (sIL-2R) can be measured in serum as a marker of T cell activation.
Purpose of the Study:
- To investigate T cell activation in alopecia areata.
- To determine if sIL-2R levels correlate with disease activity in alopecia areata.
Main Methods:
- Enzyme-linked immunosorbent assay (ELISA) was used.
- sIL-2R levels were measured in serum samples.
- Patients with alopecia areata (totalis/universalis) and healthy controls were studied during active and resting disease phases.
Main Results:
- Patients with active alopecia areata exhibited significantly higher sIL-2R concentrations compared to those in the stable phase.
- sIL-2R levels in active alopecia areata were also significantly higher than in healthy control subjects.
- sIL-2R levels were lower in the stable phase of alopecia areata compared to controls.
Conclusions:
- Elevated sIL-2R levels in active alopecia areata suggest significant T cell activation.
- These findings support a potential role for immune inflammatory mechanisms in the pathogenesis of alopecia areata.
- Further research is needed to elucidate the precise biological role of sIL-2R in this condition.